Conditions: Non-alcoholic Fatty Liver Disease (NAFLD); Dyslipidaemia
Interventions: Drug: ECC4703; Drug: Sulfasalazine; Drug: Pitavastatin
Sponsors: Eccogene
Not yet recruiting Conditions: Non-alcoholic Fatty Liver Disease (NAFLD); Dyslipidaemia
Interventions: Drug: ECC4703; Drug: Sulfasalazine; Drug: Pitavastatin
Sponsors: Eccogene
Not yet recruiting
